Komori
JCR Pharmaceuticals (4552) · FactRestated

Application of the Accounting Standard for Fair Value Measurement

First written in FY2022-Q3. 1 of 4 entries say "Restated". Latest entry: FY2023-Q2.

4entries
1years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2022-Q3 – FY2023-Q22022: 42022
Same theme, other companies
Preparing for the application of the accounting standards for fair value measurementA theme 1845 companies write about · 5 as a headwind · 3 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 196 companies compared. The sentences above are computed from all 196.Comparing 200 of the theme's 1886 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2023-Q2RestatedAnnual report

    「The Implementation Guidance on the Accounting Standard for Fair Value Measurement was applied from the beginning of the first quarter consolidated accounting period, and the new accounting policies prescribed by the guidance will be applied prospectively. This had no impact on the quarterly consolidated financial statements.」

    The application of the Implementation Guidance on the Accounting Standard for Fair Value Measurement and the absence of any impact on the quarterly consolidated financial statements were reconfirmed.
  2. FY2023-Q1Application of the Implementation Guidance on Accounting Standard for Fair Value Measurement; no impactAnnual report

    「The Implementation Guidance on Accounting Standard for Fair Value Measurement (ASBJ Guidance No. 31, 17 June 2021, hereinafter the “Fair Value Measurement Implementation Guidance”) has been applied from the beginning of the first quarter consolidated accounting period. In accordance with the transitional treatment prescribed in paragraph 27-2 of the Fair Value Measurement Implementation Guidance, the new accounting policies prescribed therein have been applied prospectively. There was no impact on the quarterly consolidated financial statements as a result.」

    The Implementation Guidance on the Accounting Standard for Fair Value Measurement was applied from the beginning of the first quarter consolidated accounting period, with no impact on the quarterly consolidated financial statements disclosed.
  3. FY2022Confirmation of annual application and no impactAnnual report

    「The Accounting Standard for Fair Value Measurement and related standards were applied from the beginning of the consolidated fiscal year, and the new accounting policies prescribed by those standards will be applied prospectively. This had no impact on the consolidated financial statements.」

    The Accounting Standard for Fair Value Measurement and related standards were applied from the beginning of the fiscal year, with no impact on the consolidated financial statements confirmed.
  4. FY2022-Q3First statedAnnual report

    「We applied the Accounting Standard for Fair Value Measurement (ASBJ Statement No. 30, 4 July 2019) and related standards from the beginning of the first quarter, and applied the new accounting policies prescribed by those standards prospectively in accordance with the transitional treatment set out in paragraph 19 of the standard and paragraph 44-2 of the Accounting Standard for Financial Instruments. This had no impact on the quarterly consolidated financial statements.」

    The Accounting Standard for Fair Value Measurement and related standards were applied from the beginning of the first quarter consolidated accounting period. The Company disclosed that there was no impact on the quarterly consolidated financial statements.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
JCR Pharmaceuticals's next results are scheduled for 2026-10-29. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Application of the Accounting Standard for Fair Value Measurement | JCR Pharmaceuticals Co.,Ltd. (4552) | Komori